A randomized, double-blind, active-controlled, parallel-group comparison of valsartan and amlodipine in the treatment of isolated systolic hypertension in elderly patients: The Val-Syst study

This publication has 25 references indexed in Scilit:

• Valsartan/Hydrochlorothiazide is Effective in Hypertensive Patients Inadequately Controlled by Valsartan Monotherapy
  Blood Pressure, 2003
• Comparative angiotensin II receptor blockade in healthy volunteers: The importance of dosing
  Clinical Pharmacology & Therapeutics, 2002
• Trough:peak ratio and smoothness index in the evaluation of 24-h blood pressure control in hypertension: a comparative study between valsartan/hydrochlorothiazide combination and amlodipine
  European Journal of Clinical Pharmacology, 2001
• Combination of hydrochlorothiazide or benazepril with valsartan in hypertensive patients unresponsive to valsartan alone
  Journal Of Hypertension, 2001
• Valsartan alone or with a diuretic or ACE inhibitor as treatment for African American hypertensives: relation to salt intake
  American Journal of Hypertension, 2001
• Prognosis of Isolated Systolic and Isolated Diastolic Hypertension as Assessed by Self-Measurement of Blood Pressure at Home
  Archives of internal medicine (1960), 2000
• Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials
  The Lancet, 2000
• Historic perspectives on the relative contributions of diastolic and systolic blood pressure elevation to cardiovascular risk profile
  American Heart Journal, 1999
• Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy, tolerability and safety compared to an angiotensin-converting enzyme inhibitor, lisinopril
  Journal of Human Hypertension, 1997
• The efficacy and safety of valsartan compared with placebo in the treatment of patients with essential hypertension
  Clinical Therapeutics, 1996